Vitamin D, Fibroblast Growth Factor 23 and Incident Cognitive Impairment: Findings from the REGARDS Study.
Vitamin D protects against cognitive decline in animals but evidence in humans has been inconsistent. Fibroblast growth factor 23 (FGF23) is a hormone that inhibits vitamin D activation yet few studies examined whether FGF23 is associated with cognitive impairment. The objective of this study was to...
Main Authors: | Bhupesh Panwar, Suzanne E Judd, Virginia J Howard, Nancy S Jenny, Virginia G Wadley, Orlando M Gutiérrez |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5094718?pdf=render |
Similar Items
-
Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults.
by: Lynae J Hanks, et al.
Published: (2015-01-01) -
Life’s Simple 7 and Incident Hypertension: The REGARDS Study
by: Timothy B. Plante, et al.
Published: (2020-10-01) -
Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle‐Aged Adults
by: Shejuti Paul, et al.
Published: (2021-08-01) -
Fine particulate matter and incident cognitive impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort.
by: Matthew Shane Loop, et al.
Published: (2013-01-01) -
Fibroblast growth factor 23 and cognitive impairment: The health, aging, and body composition study.
by: David A Drew, et al.
Published: (2020-01-01)